Global Laxative Market, By Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives, Lubricant and Emollient Laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid, Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Laxative, Pharmacy Stores, grocer/Health and Beauty Stores, Others), Distribution channel (Direct Sales, Wholesalers, Others) - Industry Trends and Forecast to 2030.
Laxative Market Analysis and Size
People who abuse laxatives can be classified into four kinds, according to a study published in the National Center for Biotechnology Information (NCBI) in 2010. According to the same study, individuals suffering from eating disorders such as anorexia or bulimia make up the largest group, with a prevalence of abuse ranging from 10% to 60%. Laxatives are medications that aid in the relief of constipation or the emptying of the intestine. Some soften or loosen the stool, while others help with bowel movement by increasing the frequency with which the big colon contracts. It is sometimes used to cleanse bowel feces during operations or surgery that involves the lower colon and is considered to witness a significant growth in the global laxative market.
Data Bridge Market Research analyses that the global laxative market which was USD 6.50 billion in 2022, is expected to reach USD 10.98 billion by 2030, and is expected to undergo a CAGR of 6.3% during the forecast period 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Laxative Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Type (Osmotic Laxatives, Stimulant Laxatives, Bulk Laxatives, Lubricant and Emollient Laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid, Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Laxative, Pharmacy Stores, grocer/Health and Beauty Stores, Others), Distribution channel (Direct Sales, Wholesalers, Others) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.) |
Market Opportunities |
|
Market Definition
Laxatives are supplements that can aid in the loosening of stools as well as the facilitation of easy and increased bowel movements. If someone is suffering from constipation, laxatives might be quite helpful. Laxatives can also help with pain caused by firm and dry stools. Laxatives are usually taken three times each week. This is preferred as a form of treatment since it enters the scene when other methods of treating and curing constipation are unsuccessful. Constipation can usually be treated without the use of laxatives. These are commonly accessible as over-the-counter (OTC) medications that can be used without a doctor's prescription.
Global Laxative Market Dynamics
Drivers
- Rising Prevalence of Eating Disorders
Individuals with eating disorders, especially bulimia nervosa, may misuse or abuse laxatives as a means of purging after binge-eating episodes. This misuse is not a legitimate medical indication but rather a harmful behavior associated with the disorders. The misuse of laxatives among individuals with eating disorders can lead to a range of health risks, including electrolyte imbalances, dehydration, and gastrointestinal damage. The severity of these risks depends on the extent of laxative abuse.
- Rising Geriatric Population
The geriatric population has a significant impact on the laxative market due to the increased prevalence of constipation and gastrointestinal issues in this age group. Constipation is more common among the elderly, with various factors, such as reduced mobility, medication use, and age-related changes in bowel function, contributing to this issue. As a result, the geriatric population has a higher demand for laxative products.
Opportunities
- Increasing Research and Development Activities
The introduction of new laxative products can diversify the product portfolio available in the market. This can provide consumers with a wider range of options, including products that may better suit their preferences and needs. Increased R&D activities can lead to the development of innovative laxative products. Researchers may explore novel formulations, delivery methods, and mechanisms of action to create more effective and tolerable laxatives.
- Increasing Healthcare Infrastructure
An enhanced healthcare infrastructure often leads to better diagnostic capabilities and increased awareness of gastrointestinal conditions, including constipation. This can result in more individuals seeking medical attention for these issues, potentially increasing the demand for laxatives. A growing healthcare infrastructure may incorporate telemedicine and telehealth solutions, making it easier for individuals to access medical advice and treatment recommendations for digestive health concerns. This can lead to more informed use of laxatives.
Restrains/Challenges
- Strict Regulations and Guidelines
Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) in the U.S. and the European Medicines Agency (EMA) in Europe, set safety and efficacy standards for laxative products. These guidelines help ensure that laxatives are safe for use and effective in relieving constipation or managing related gastrointestinal issues.
- Limited Access to Services
The shortage of skilled professionals may lead to delays in the diagnosis and treatment of gastrointestinal disorders that require laxatives. Patients might experience symptoms for longer periods before receiving appropriate medical attention. Skilled professionals are responsible for developing comprehensive treatment plans for patients with gastrointestinal issues. The absence of such professionals may result in suboptimal treatment plans, impacting the effectiveness of laxative therapy.
- High Cost of Drug Development
Developing new drugs, whether they are laxatives or other pharmaceuticals, is expensive due to the need for extensive research, clinical trials, and regulatory compliance. These high development costs can lead to a need for higher prices to recoup investments. In the laxative market, this could translate to higher prices for newly developed laxative products.
This global laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2021, Purdue Pharma L.P. announced the launch of two Senokot Dietary Supplement Products namely Senokot Laxative Gummies – Blueberry Pomegranate flavor and Senokot Laxative Tea. Senokot Dietary Supplement Laxative Gummies - Blueberry Pomegranate Flavor is a new flavor of Senokot Laxative Gummies for gentle overnight constipation treatment. Senokot Laxative Gummies are made from a natural senna plant and are used to relieve occasional constipation. Senokot Dietary Supplement Laxative Tea is a sweet tea with delicate cinnamon and floral flavors made from natural and organic senna and chamomile. Relax with a cup before bedtime to relieve occasional constipation overnight
Global Laxative Market Scope
The global laxative market is segmented on the basis of type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Osmotic Laxatives
- Stimulant Laxatives
- Bulk Laxatives
- Lubricant and Emollient Laxatives
Flavors
- With Flavor
- Fruit
- Herbal
- Others
- Without Flavor
Source
- Natural
- Psyllium
- Rhubarb
- Senna
- Slippery elm
- Synthetic Phenolphthalein
- Bisacodyl
- Picosulfate
- Oxyphenisatin
- Others
Indication
- Chronic Constipation
- Irritable Bowel Syndrome with Constipation
- Opioid-Induced Constipation
- Acute Constipation
- Others.
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid
- Gels
- Suppositories
- Others
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Home Healthcare
- Pharmacy Stores
- Grocer/Health and Beauty Stores
- Others
Mode of Purchase
- Prescription
- Over-the-counter (OTC)
Route of Administration
- Oral
- Rectal
Distribution Channel
- Direct Sales
- Wholesalers
- Others
Global Laxative Market Regional Analysis/Insights
The global laxative market is analysed and market size insights and trends are provided by country, type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.
The countries covered in the global laxative market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global laxative market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increasing usage of laxatives and rising healthcare expenditure will further propel the market's growth rate in this region. Additionally, the growing presence of major key players and rise in adoption of newer technologies will further propel the market's growth rate in this region.
Asia-Pacific is expected to be the fastest-growing region in the global laxative market during the forecast period of 2023-2030 due to increasing investment in innovative R&D for novel drug products in this region. Also, development of healthcare infrastructure and the rising number of generic drug manufacturer will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global laxative market The data is available for historic period 2015-2020
Competitive Landscape and Global Laxative Market Share Analysis
The global laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global laxative market.
Some of the major players operating in the global laxative market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Merck & Co., Inc. (U.S.)
- AstraZeneca (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Lupin (India)
- Fresenius Kabi AG (Germany)
- Aurobindo Pharma (India)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Eli Lilly and Company (U.S.)
SKU-